BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20431442)

  • 1. Opioid tapering in children: a review of the literature.
    Fisher D
    AACN Adv Crit Care; 2010; 21(2):139-45. PubMed ID: 20431442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid and benzodiazepine withdrawal syndromes in the paediatric intensive care unit: a review of recent literature.
    Birchley G
    Nurs Crit Care; 2009; 14(1):26-37. PubMed ID: 19154308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid tapering in hematopoietic progenitor cell transplant recipients.
    Pederson C; Parran L
    Oncol Nurs Forum; 2000 Oct; 27(9):1371-80. PubMed ID: 11058969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation.
    Ista E; van Dijk M; Gamel C; Tibboel D; de Hoog M
    Crit Care Med; 2008 Aug; 36(8):2427-32. PubMed ID: 18596622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid and Benzodiazepine Weaning in Pediatric Patients: Review of Current Literature.
    Fenn NE; Plake KS
    Pharmacotherapy; 2017 Nov; 37(11):1458-1468. PubMed ID: 28891099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an opioid-taper algorithm for hematopoietic cell transplant recipients.
    Parran L; Pederson C
    Oncol Nurs Forum; 2000 Jul; 27(6):967-74. PubMed ID: 10920835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients.
    Franck LS; Naughton I; Winter I
    Intensive Crit Care Nurs; 2004 Dec; 20(6):344-51. PubMed ID: 15567675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients: a systematic review and conceptual model.
    Best KM; Boullata JI; Curley MA
    Pediatr Crit Care Med; 2015 Feb; 16(2):175-83. PubMed ID: 25560429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma-related symptoms.
    Kanabar D; Dale S; Rawat M
    Clin Ther; 2007 Dec; 29(12):2716-23. PubMed ID: 18201589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iatrogenic Opioid Withdrawal in Critically Ill Patients: A Review of Assessment Tools and Management.
    Chiu AW; Contreras S; Mehta S; Korman J; Perreault MM; Williamson DR; Burry LD
    Ann Pharmacother; 2017 Dec; 51(12):1099-1111. PubMed ID: 28793780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and effect of opioid analgesia in undifferentiated abdominal pain in children: a review of four studies.
    Sharwood LN; Babl FE
    Paediatr Anaesth; 2009 May; 19(5):445-51. PubMed ID: 19453578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: a literature review. "Assessment remains troublesome".
    Ista E; van Dijk M; Gamel C; Tibboel D; de Hoog M
    Intensive Care Med; 2007 Aug; 33(8):1396-406. PubMed ID: 17541548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients.
    Honey BL; Benefield RJ; Miller JL; Johnson PN
    Ann Pharmacother; 2009 Sep; 43(9):1506-11. PubMed ID: 19690220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Withdrawal Assessment Tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients.
    Franck LS; Harris SK; Soetenga DJ; Amling JK; Curley MA
    Pediatr Crit Care Med; 2008 Nov; 9(6):573-80. PubMed ID: 18838937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid tapering and weaning protocols in pediatric critical care units: a systematic review.
    Bichaff P; Setani KT; Motta EHG; Delgado AF; Carvalho WB; Luglio M
    Rev Assoc Med Bras (1992); 2018 Oct; 64(10):909-915. PubMed ID: 30517238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid withdrawal signs and symptoms in children: frequency and determinants.
    Fisher D; Grap MJ; Younger JB; Ameringer S; Elswick RK
    Heart Lung; 2013; 42(6):407-13. PubMed ID: 24008186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children.
    Darnell CM; Thompson J; Stromberg D; Roy L; Sheeran P
    Pediatrics; 2008 May; 121(5):e1363-71. PubMed ID: 18411237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
    Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
    Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structured review of studies on health-related quality of life and economic evaluation in pediatric acute lymphoblastic leukemia.
    Pickard AS; Topfer LA; Feeny DH
    J Natl Cancer Inst Monogr; 2004; (33):102-25. PubMed ID: 15504922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.
    McGregor C; Machin A; White JM
    Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.